Pharmafile Logo
Pharmafocus logo
Advanced Search

drug safety

Showing 15 posts of 32 posts found.

Abbott Park

Abbott’s Meridia ‘increases heart attack risk’

September 2, 2010
Sales and Marketing Abbott, Meridia, drug safety

Abbott’s weight-loss drug Meridia increases the risk of stroke and heart attack in patients with heart disease, according a study …

News
Blog footer

Digital Pharma: Online trial safety reporting

June 21, 2010
Research and Development FDA, MHRA, digital research, drug safety

From September all serious adverse events that occur during clinical trials in the UK will have to be reported electronically …

News

FDA to make safety reviews public

June 16, 2010
Research and Development, Sales and Marketing FDA, drug safety

The US medicines regulator is to make safety reviews of recently approved prescription medicines more readily available to the public. …

News

Boehringer denies Micardis cancer link

June 14, 2010
Sales and Marketing ACE-inhibitors, ARB, Boehringer, Micardis, drug safety

Boehringer Ingelheim has given a robust rebuttal to a Lancet report implicating its hypertension drug Micardis (telmisartan) in scares about …

News

FDA says rotavirus vaccines are safe

May 17, 2010
Manufacturing and Production drug safety, rotarix, rotateq

The US Food and Drug Administration has taken the advice of its advisors and given its backing to resume the …

News

FDA backs rotavirus vaccine despite contamination

May 13, 2010
Sales and Marketing GSK, Rotavirus, Vaccine, drug safety, rotarix

FDA advisors have recommended two rotavirus vaccines licensed in the US should continue to be used, despite contamination with a …

News

Rising pharma recalls in UK ‘a concern’, says report

January 29, 2010
Manufacturing and Production drug safety, medical devices, production, recalls

Pharmaceutical and medical device recalls more than quadrupled in the UK between 2004 and 2008, with the majority caused by …

News

Observational studies will help answer growing safety demands

September 8, 2009
Research and Development ICON, drug safety

The pharmaceutical industry is ready to adapt to growing drug safety requirements, but understanding of how it can capture safety …

News

EMEA makes adverse drug reaction research a priority

August 12, 2009
Research and Development, Sales and Marketing Europe, drug safety

Adverse drug reaction in hyperactive children has been made a key research priority for next year by the European Medicines …

News

New FDA head aims for aggressive enforcement

August 11, 2009
Research and Development, Sales and Marketing FDA, US, drug safety

The new head of US regulator the FDA has set out a vision to support public health, through tighter laws …

News

Depression warnings for Chantix and Zyban

July 7, 2009
Research and Development, Sales and Marketing Chantix, FDA, US, drug safety

Pfizer and GSK's smoking cessations drugs will have to carry strong warnings of depression and other mental health adverse events …

News

Safety concerns give Raptiva ‘no way back’

March 2, 2009
Research and Development Raptiva, drug safety

News

Working Life: Sam Knivett

January 23, 2009
Business Services, Research and Development Pfizer, UK, WL, Working Life, careers, compliance, drug safety

How did you find your way into your current role?From the age of 11 I wanted to be a farmer. …

Feature

Drug regulation: still room for improvement

August 15, 2008
Research and Development, Sales and Marketing drug safety, medicines act

This year is a bit of a jamboree of health-related anniversaries, with the NHS celebrating 60 years and the Medicines …

Feature

Safety first

December 10, 2007
Research and Development, Sales and Marketing clinical trials, drug development, drug safety

There is a tide of change in drug safety within the pharmaceutical industry.  Internal and external forces are pushing drug …

Feature
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026